ABSTRACT: n-Hexane neuropathy has been described after glue sniffing and industrial exposure. Onset may be subacute and reminiscent of Guillain-Barré syndrome. Although the primary pathology is axonal, electrophysiologic evaluation is frequently most remarkable for conduction slowing. We describe a patient with a severe subacute neuropathy following nhexane exposure via glue sniffing. Although symptoms worsened after termination of exposure (''coasting''), strength gradually improved to near normal. Sources of toxic exposure should be sought in all patients with subacute demyelinating neuropathies.
developed, causing difficulty with writing and buttoning shirts. There was a 25-pound weight loss. He was referred to us for treatment of acute inflammatory demyelinating polyradiculoneuropathy (Guillian-Barré syndrome), although his course was more characteristic of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). He had a history of schizophrenia, with auditory hallucinations requiring chronic neuroleptic use. Medications at the time of initial evaluation were fluoxetine, benztropine, and chlorpromazine. He initially denied current substance use but admitted to previous polysubstance use including crack cocaine and amphetamines. His parents, however, described several months of repeated rubber cement inhalation (''huffing'') with a 1-month history of heavy use, one bottle daily. n-Hexane was the primary ingredient of the rubber cement used. Laboratory Evaluation. Laboratory evaluation included normal electrolytes, blood urea nitrogen, creatinine, calcium, magnesium, phosphate, liver function tests, and complete blood count. A sedimentation rate, serum protein electrophoresis, antinuclear antibody, urine porphyrin screen, and 24-h urine heavy metal assay were normal. Spinal fluid protein was 63 mg/dL, with a glucose of 57 and one lymphocyte. A sural nerve biopsy was performed, revealing decreased density of large myelinated fibers with several focally swollen axons. Electron microscopy of the swollen axons revealed large collections of neurofilaments (Fig. 1) .
Electrophysiologic Evaluation. Nerve conduction studies revealed borderline low sensory nerve action potential (SNAP) amplitudes with minimally prolonged sensory distal latencies. Compound muscle action potential (CMAP) amplitudes were diminished, motor distal latencies were prolonged, and motor conduction velocities were reduced (Table 1) . There was conduction block in several locations: median nerve in the forearm, ulnar nerve in the forearm (Fig. 2) , peroneal nerve across the knee, and tibial nerve in the leg. F responses were absent. Needle electromyography revealed profuse positive waves and fibrillation potentials in limb muscles, particularly distally, but not in paraspinal muscles, with diminished recruitment of mildly polyphasic units. Limb temperature was maintained greater than 32°C.
Clinical Course. After admission to the hospital and discontinuation of glue sniffing, weakness and numbness progressed over 1 week until he was wheelchair bound. At nadir, 3 weeks later, distal arm strength was graded as 2/2, and only trace movements were present beneath the knee. Slow improve-FIGURE 1. Electron micrograph of a swollen axon demonstrating massed neurofilaments (arrowhead) adjacent to myelin sheath (arrow). ment followed, and 1 year later strength was normal except for 5−/5− ankle dorsiflexor strength; sensation was diminished distally in the hands and feet, and reflexes had returned. Electrophysiologic evaluations paralleled clinical recovery. There was an initial decrease in motor evoked amplitudes and motor conduction velocities 1 month after initial evaluation. With clinical recovery, however, all electrophysiologic parameters improved (Fig. 3) . Eleven months after presentation nerve conduction studies had normalized in the arms and improved dramatically in the legs. The peroneal CMAP amplitude with recording over the extensor digitorum brevis was still reduced at 0.04 mV, although the CMAP amplitude recording over the anterior tibialis had returned to normal (3.4 mV). Tibial and peroneal motor conduction velocities remained diminished (31 and 27 m/s, respectively), and the minimal latency of the tibial F response was mildly prolonged at 57.8 ms (normal < 55 ms).
DISCUSSION
Peripheral neuropathy is well described after exposure to n-hexane. Industrial exposure has occurred in a number of settings including cabinet, 10, 19 laminating, 32, 33 pharmaceutical, 34 adhesive bandage, 29 raincoat, 25 and printing 5, 6 industries, as well as in ball, 11 adhesive paper, 22 and sandal and shoe manufacturing. 12, 13, 20, 23, 24 There are also reports of glue sniffers or ''huffers'' developing peripheral neuropathy. [1] [2] [3] [4] [5] [6] 8 Severe cases related to industrial exposure are clinically indistinguishable from cases secondary to recreational inhalation. Numbness is typically noted in the feet and hands and rarely spreads beyond the knees or wrists. Weakness develops in the legs, then the arms, and tends to affect distal muscles most. In severe cases, marked distal atrophy and proximal weakness occur. Muscle cramping and weight loss are common. In many industrial cases the onset is gradual, with predominant sensory findings. 26 In one large series of 93 patients, 57% had a sensory neuropathy, and only 8.6% also had amyotrophy. Distal lower extremity numbness was the first symptom in 88% of patients. 13 In glue sniffers and severely affected industrial workers the onset may be subacute and reminiscent of Guillain-Barré syndrome. 9, 14, 22, 31 After exposure is terminated, patients may continue to worsen for many weeks, as in our patient. The ''coasting'' phenomenon is well described, both clinically and electrophysiologically, 11, 14 and is observed in other toxic neuropathies including acrylamide, thalidomide, triorthocresylphosphate, 11 and the multiple cranial neuropathies of trichloroethylene. 3 The pathologic hallmark of n-hexane neuropathy is loss of large myelinated fibers with focally enlarged ''giant'' axons filled with neurofilaments and associated thinning of the overlying myelin. In addi- tion, paranodal myelin retraction and occasional segmental demyelination are observed. 14, 28, 31 These features are the likely pathologic substrate for the electrophysiologic features of demyelination. Such findings are not unique to n-hexane neuropathy, having been described in methyl n-butyl ketone, acrylamide, triorthocresyl phosphate, and inherited giant axonal neuropathy. 7, 31 Similar axonal enlargement of a lesser degree may be seen after exposure to vinca alkaloids and colchicine. 31 Schaumburg has suggested that axonal swellings begin in distal but nonterminal regions in a multifocal fashion, with subsequent spread to more distal and proximal segments and breakdown of nerve fibers distally. 27 Based on pathologic evidence, the primary lesion in n-hexane neuropathy is axonal, beginning distally with proximal spread, with secondary myelin changes. The exact mechanism is uncertain, although it is speculated that neurofilaments are the primary site of injury. The active metabolite is thought to be 2,5 hexanedione.
Electrophysiologic findings depend on the neuropathy's severity. One study of 20 industrial workers exposed to n-hexane with normal neurologic examinations and without neuropathic symptoms revealed normal nerve conduction velocities and F responses, but diminished SNAP amplitudes compared to agematched normals. 5, 21 Similar findings have been reported in patients without neurological disease exposed to n-methyl butyl ketone. 1 Of 56 workers exposed to n-hexane in an offset printing shop, 46% had subclinical peripheral neuropathy evident on nerve conduction studies, with markedly diminished SNAP amplitudes, diminished motor conduction velocity, mildly prolonged motor distal latencies, and reduced CMAP amplitudes. Among those with symptomatic neuropathy, motor nerve conduction velocities were markedly slowed. There was no relationship between duration of employment and development of neuropathy, suggesting that host factors such as individual variability in the hepatic p-450 system play a role. 5 Many others have emphasized the reduction in motor conduction velocities in severely affected patients. 5, 9, [11] [12] [13] [14] [16] [17] [18] 22, 25, 31 Motor conduction velocities are slowest distally, with only mildly slowed proximal conduction velocity (e.g., between the neck and axilla). F waves are usually absent. 17 Conduction block was observed in our patient and has been described by several others. 4, 15, 17 Using the criteria of Asbury and Cornblath, 2 our patient met formal criteria for a primary demyelinating neuropathy. Among 27 neuropathy patients with industrial exposure, 67% had diminished conduction velocity in two or more nerves, 74% had partial conduction block or temporal dispersion in one or more motor nerves, 78% had two or more prolonged distal latencies, and 59% had absent or prolonged F responses in two or more locations. All four criteria for acquired demyelinating neuropathy were met by 37%, while 26%, 19%, and 15% met three, two, and one criteria, respectively. 17 Needle electromyography reveals fibrillation potentials and positive waves in involved distal muscles. While electrophysiologic features of demyelination are frequently prominent, the progression from reduced sensory evoked amplitudes to reduced motor evoked amplitudes and reduced motor conduction velocities indicate a primary axonal pathology, in accordance with pathological findings.
Prognosis for recovery from n-hexane neuropathy depends on the severity, with excellent clinical outcome in most patients with sensory neuropathy. Among 93 industrial workers, 57% of whom had a sensory neuropathy, 34% a sensorimotor neuropathy, and 9% amyotrophy, 92% achieved a full recovery after 4 years, with the remaining patients left with only sensory abnormalities. 13 There are relatively few data on recovery in severely affected huffers, however. Among 3 huffers unable to walk at the peak of their neuropathy, 2 recovered independent ambulation with persistent footdrops, and 1 achieved full recovery. 14, 15, 31 Electrophysiologic recovery paralleled clinical improvement. 15 Several aspects of our patient are of interest. Unlike most cases of industrial n-hexane neuropathy, he developed severe weakness, similar to other reports of n-hexane neuropathy in glue sniffers. Despite primarily axonal pathology, nerve conduction abnormalities met formal criteria for a primary demyelinating neuropathy, leading to the erroneous diagnosis of acute inflammatory demyelinating polyradiculoneuropathy. n-Hexane exposure was evident only after direct, separate questioning of his parents concerning substance abuse and toxic exposure. Sources of toxic exposure should be sought in any patient with a subacute neuropathy with demyelinating features on nerve conduction studies and distal denervation on needle electromyography. While there are minimal prognostic data in the literature, our experience demonstrates excellent clinical and electrophysiologic recovery, despite severe weakness and denervation.
